Product Images Pioglitazone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Pioglitazone Hydrochloride NDC 65862-513 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 shows the time course for changes in HbA1c in this 26-week study - pioglitazone fig1

Figure 1 shows the time course for changes in HbA1c in this 26-week study - pioglitazone fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablet Bottle) - pioglitazone fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablet Bottle) - pioglitazone fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig3

Pioglitazone Tablets are a prescription medication containing 15mg of pioglitazone hydrochloride USP per tablet. This medication is used to treat diabetes and is available in a packaging unit of 30 unit-dose tablets (3x10) which should be stored between 20° to 25°C (68° to 77°F) to protect from moisture and humidity. It's recommended to keep this and all drugs out of reach of children. Accompanying literature for complete information on the administration and dosage should be provided to each patient when dispensing this medication. Any outpatient use of this medication should be accompanied by a child resistant container. Dotted lines should not be printed to allow the Over Printing Zone.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - pioglitazone fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - pioglitazone fig4

Pioglitazone Tablets, USP is a prescription medicine used to control high blood sugar levels in individuals with type 2 diabetes. Each tablet contains 30 mg of Pioglitazone hydrochloride USP equivalent to pioglitazone. Patients are advised to read the accompanying medication guide. The recommended dosage varies and should be followed as prescribed by a healthcare provider. The medication should be stored at room temperature between 20°C - 25°C and protected from moisture and humidity. It should be dispensed in a light-resistant container and kept out of the reach of children. Aurobindo Pharma USA, Inc. distributes the medication in the United States under the code TS/DRUGS/19/1993.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig5

Pioglitazone Tablets, USP is a medication containing up to 30 mg of pioglitazone hydrochloride USP in each tablet. The package contains 30 tablets divided into three unit-dose sets. The tablets should be stored in a container that is protected from moisture and light, and kept out of reach of children. The package should include a medication guide for patients. The package also has an overprinting zone, and a dotted line indicating an unvarnished zone which should not be printed. The code suggests that it was produced in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg (30 Tablet Bottle) - pioglitazone fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg (30 Tablet Bottle) - pioglitazone fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg Blister Carton (3 x 10 Unit-dose) - pioglitazone fig7

Pioglitazone Tablets, USP is an oral medication used to control blood sugar levels in those with type 2 diabetes. Each tablet contains 45 mg of Pioglitazone hydrochloride USP equivalent. It is advised to keep these tablets and all drugs away from children and store them in a USP tight, light-resistant container at 20° to 25°C (68° to 77°F). The unit-dose package is not child-resistant and a child-resistant container should be used when dispensed for outpatient use. The package contains 30 (3 x 10) unit-dose tablets and is distributed by Aurobindo Pharma USA, Inc. The medication guide should be given to each patient by the pharmacist.*

chemical structure - pioglitazone str

chemical structure - pioglitazone str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.